MedTrace Logo

Low-dose Radiotherapy in iNHL

NCT05543070 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2022-09-16

No results posted yet for this study

Summary

The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of low-dose radiotherapy (3 Gy\*4f) in indolent lymphoma.

Conditions

  • Indolent Lymphoma
  • Low-dose Radiotherapy

Interventions

RADIATION

Low-dose radiotherapy

Electron Beam/3D-CRT/IMRT/VMAT

Sponsors & Collaborators

  • Shanxi Province Cancer Hospital

    collaborator OTHER

  • Beijing Tongren Hospital

    collaborator OTHER

  • Fujian Medical University Union Hospital

    collaborator OTHER

  • Chinese Academy of Medical Sciences

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-07-01
Completion
2025-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543070 on ClinicalTrials.gov